Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04

Z Varasteh, S Mohanta, S Robu… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Heart failure remains a major source of late morbidity and mortality after myocardial infarction
(MI). … fibroblasts in the injured myocardium predicts the quality of cardiac remodeling after

[HTML][HTML] Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

JR Teerlink, R Diaz, GM Felker… - New England …, 2021 - Mass Medical Soc
… Among patients with heart failure and a reduced ejection, … of a heart-failure event or death
from cardiovascular causes than … cardiac ischemic events that included myocardial infarction, …

Adverse cardiac remodelling after acute myocardial infarction: old and new biomarkers

AE Berezin, AA Berezin - Disease Markers, 2020 - Wiley Online Library
at early period of … cardiovascular (CV) complications, late adverse cardiac remodelling may
be a major risk factor for one-year mortality and postponded heart failure manifestation after

[HTML][HTML] Pitavastatin to prevent cardiovascular disease in HIV infection

SK Grinspoon, KV Fitch, MV Zanni… - New England …, 2023 - Mass Medical Soc
… event, which was defined as a composite of cardiovascular death, myocardial infarction, …
The risk of atherosclerotic cardiovascular disease, including myocardial infarction and stroke, is …

2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults

GJ Pearson, G Thanassoulis, TJ Anderson… - Canadian journal of …, 2021 - Elsevier
… The primary outcome of death from coronary heart disease, nonfatal MI, fatal or nonfatal
ischemic stroke, or unstable angina requiring hospitalization was lower with alirocumab (9.5% …

Biomarkers in heart failure: the past, current and future

M Sarhene, Y Wang, J Wei, Y Huang, M Li, L Li… - Heart failure …, 2019 - Springer
… of heart failure (HF), it still remains a serious syndrome with substantial morbidity, mortality,
… the current improvements in other cardiovascular diseases (like myocardial infarction), the …

[HTML][HTML] Polypill with or without aspirin in persons without cardiovascular disease

S Yusuf, P Joseph, A Dans, P Gao, K Teo… - New England …, 2021 - Mass Medical Soc
… , stroke, resuscitated cardiac arrest, heart failure, or … was death from cardiovascular causes,
myocardial infarction, or … for the prevention of cardiovascular diseases in the community. …

Global burden of heart failure: a comprehensive and updated review of epidemiology

G Savarese, PM Becher, LH Lund… - Cardiovascular …, 2022 - academic.oup.com
… 6 months following an acute myocardial infarction compared with … Causes of death in heart
failure patients worldwide. a—… In a community-based sample from the FHS, between 1971 …

[HTML][HTML] Angiotensin–neprilysin inhibition in acute decompensated heart failure

EJ Velazquez, DA Morrow, AD DeVore… - New England …, 2019 - Mass Medical Soc
… Rates of short-term unplanned rehospitalization and death associated with acute decompensated
heart failure are high (21% and 12%, respectively). Despite multiple trials of promising …

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of …

WC Meijers, A Bayes‐Genis, A Mebazaa… - … of heart failure, 2021 - Wiley Online Library
… to establish the presence of type 1 myocardial infarction (MI) or acute HF-related injury. In …
an increased risk for new-onset HF and all-cause mortality after adjustment for natriuretic …